APE/ref-1 levels have been shown to be elevated in various types of cancers such as cervical, prostate, ovarian and germ cell tumours (Xu et al, 1997; Herring et al, 1998; Moore et al, 2000; Kelley et al, 2001; Robertson et al, 2001). Here, APEX1 is linked to cancer.